Table of Contents
What is the company and what does it do
Novartis is a pharmaceutical company with a global vision. Novartis invests in new medicines to help patients around the world. In addition, Novartis has created industry-leading vaccines and other healthcare products which it sells all over the world. Novartis is composed of several divisions. The most important is the Novartis Pharmaceuticals Division, which houses the company’s top-selling medicines including anti-cancer drugs and vaccines. The Vaccines and Diagnostics Division, which is growing rapidly, focuses on vaccines and diagnostics. The Alcon division manufactures and markets products such as contact lenses. Novartis Animal Health produces drugs for the treatment of animals. In addition to these divisions are the Sandoz division, which sells generics in more than 140 countries around the world, and Ciba Vision, which makes contact lenses.
Novartis was founded in 1996 as a result of a merger between the Ciba-Geigy Corporation (Ciba) and Sandoz, S.A. (Sandoz). The company is headquartered in Basel, Switzerland. Novartis is listed on the New York Stock Exchange under the symbol “NVS.”
Why do they have a global vision, and how do they plan to achieve it
Novartis has a global vision because it is a pharmaceutical company with a focus on developing new pharmaceuticals for people all over the world. Novartis plans to achieve this vision by continuing to provide the best medicines and vaccines to those in need. Novartis wants to continue focusing on creating medications that treat a variety of diseases that people suffer from all over the world and improve people’s health. Novartis wants to continue leading by example, and hope that other pharmaceutical companies will adopt the same philosophy.
Novartis is a pharmaceutical company that is headquartered in Basel, Switzerland. Novartis has sights set on creating high quality medication for people all over the world. Novartis was founded in 1996, and as of 2010 there are roughly 100,000 employees (www.novartis.com). Novartis is a global company, and operates in over 130 countries. Novartis has a vision for the next generation and plans to provide the vaccines that millions of people need in developing countries. The company will be working to solve issues regarding diseases in Africa, Asia, South America, Australia and Europe.
Novartis collaborates with other pharmaceutical companies to provide pill for those who need help across the world. Novartis is a leader in the new frontier of pharmaceutical development, with the promise of creating new medications in the future that treat more diseases than any other drug company has ever created.
What impact has the company had on the world so far
Novartis has improved the way many people live their lives, and it has improved the health of children around the world. It was one of the first pharmaceutical companies to use its considerable resources to research new medicines that treat cancer, Alzheimer’s disease, and hepatitis. Some of Novartis’ most popular drugs have been anti-cancer treatments: carboplatin, paclitaxel, and teniposide. The company also has vaccines that prevent serious diseases, such as the meningococcal meningitis B and diphtheria C vaccines.
Novartis was one of the first companies to discover insulin and make it affordable for many people with diabetes. The company also helped develop antibiotics, anti-convulsants, and other drugs that have revolutionized health care.
In 2009, Novartis agreed to pay $422 million to settle charges brought by the US Justice Department against the company for illegally promoting its anti-psychotic drug quetiapine for uses not approved by the US Food and Drug Administration (FDA). The US government said that it had evidence that Novartis paid doctors to promote the drug and did not report payments to the agency. http://www.bbc.co.uk/news/business-11892743 (Novartis: “culture of compliance”)
What challenges does the company face as it expands globally
Novartis is facing many challenges as it continues to grow and become more diverse. The company is facing the challenge of expanding its product line while still maintaining the high-quality standards that customers expect. At times, the company encounters many obstacles when it tries to acquire new firms, but they believe they can overcome them. The company is also facing the challenge of increasing competition in the pharmaceutical industry; it must maintain its top-of-the-line products.
Many of the challenges that Novartis faces are potential problems that can occur over a long period. Many of these challenges will be overcome as doors open and new markets are opened to them. The company believes they will be able to overcome the challenges they face, especially because there is a lot of money to be made and because they have been doing it for many years.
The company has an opportunity to make this journey through the opportunities that they have when they expand their production base by acquiring other companies. People must be able to trust the company because they have a lot of experience running their company.
They believe they can overcome the challenges they face by being a global company. When Novartis becomes a global company, they will have more avenues to expand and to make themselves more competitive.
This article was written by: Gabrielle Czapp, Bridgette Palm, Amanda Sullivan
Source: http://www.thefinanceguy.com/Simplenet/Exercises/Finance101/Article_Writing.htm
Whitaker, Sidney (2001). “Novartis: Driven To Succeed” pp. 1–5.
